Financing Early-Stage Therapeutics: Interview with Dr. Yvonne Yamanaka of venBio
venBio has a different profile from a typical venture capital firm: each member of the investment team holds a medical doctorate, a scientific doctorate, or both. Dr. Yamanaka shares how venBio assesses the market potential of therapeutics and technologies that may be years away from reaching patients.